HI TECH PHARMACAL CO INC·4

Nov 9, 10:37 AM ET

SELTZER DAVID S 4

4 · HI TECH PHARMACAL CO INC · Filed Nov 9, 2012

Insider Transaction Report

Form 4
Period: 2012-11-07
SELTZER DAVID S
DirectorCEO, President, Sec'y, Treas.10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-11-07+50,00050,000 total
    Exercise: $31.93From: 2013-11-07Exp: 2022-11-07Common Stock (50,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    223,877
  • Common Stock

    1,235,945
Footnotes (3)
  • [F1]Stock option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan.
  • [F2]The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  • [F3]Other than the option to acquire 50,000 shares reflected on this form as acquired by the filer as a result of the option grant, the filer is also the holder of additional options to acquire 612,500 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 662,500 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT